| Global Research Trends

Wednesday, 15 May 2019

Lung Cancer Therapeutics Market to Perceive Substantial Growth By 2026

Lung cancer is a malignant lung tumor, which is characterized by uncontrolled division and growth of cells in the lungs. The ability of lungs to provide oxygen into the bloodstream decreases with increasing size of tumor. The lung carcinoma is classified as, non-small cell and small cell lung cancer and originates from the epithelial cells. Lung cancer has the highest mortality rate globally, where exposure to asbestos, cigarette and pipe smoking is attributed the foremost reason. Major symptoms of lung cancer includes, body mucus, chest pain, weight loss, and coughing. Chemotherapy, immunotherapy, vaccines, and radiation therapy are the common lung cancer treatments.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/702

Rising incidences of non-small cell lung cancer is expected to drive the global lung cancer therapeutics market

According to the World Health Organization estimates in 2017, 1.8 million new lung cancer cases were diagnosed in 2012 globally accounting for the leading causes of morbidity and mortality. The launch of innovative radiation therapies, premium priced drugs, and rising incidences of non-small cell lung cancer (NSCLC) are the major driving factors for the growth of the market. The rising demand for targeted therapies is likely to have an optimistic impact over the lung cancer therapeutics market in the forecast period. Targeted therapies block the growth by targeting cancer-specific proteins, cells, and tissues that lead to cancer survival and division, without damaging the healthy cells. They are also proved to have higher efficiency over conventional therapies like platinum-based chemotherapy, surgical resection, and radiation therapy.

Higher carcinoma lung population dominates the lung cancer therapeutics market in North America

Regional segmentation of the lung cancer therapeutics market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East, and Africa. According to the American Cancer Society estimates of 2017, approximately 195,000 people are suffering from NSCLC every year in the U.S. where, the number of deaths from NSCLC is recorded to be around 135,000, thus increasing the demand for lung cancer therapeutics in North America.

New product launches with higher efficiency forms a major growth strategy of market players

The key players operating the lung cancer therapeutics market are Pfizer, Celgene, F. Hofmann-La Roche, AstraZeneca and Eli Lilly. The key players adopt various strategies such as, development of efficient drugs, acquisition and mergers, geographical expansion and major investment in research and development to maintain their position in the market. Other prominent vendors include ARIAD Pharmaceuticals, OSE Immunotherapeutics, Novartis, Bristol-Myers Squibb, OncoGeneX.

Lung Cancer Therapeutics Market Taxonomy -

The global lung cancer therapeutics market is segmented on the basis of therapy, distribution channel, and geography

On the basis of therapy, the global lung cancer therapeutics market is segmented into:

Chemotherapy
Gemzar
Alimta
Paraplatin
Taxotere
Navelbine
Targeted therapy
Avastin
Tarceva
Iressa
Gilotrif
Radiotherapy
Systemic Radiotherapy
External Beam Radiotherapy
Internal Radiotherapy

For More Information, Browse Full Report Here: https://www.coherentmarketinsights.com/ongoing-insight/lung-cancer-therapeutics-market-702

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Intraocular Lens Market Status and Analysis 2017-2025

Intraocular Lens (IOL) implantation enables restoration of normal vision and significantly reduces problems associated with cataract spectacles and contact lenses. Surgical techniques for extracting the human lens continued over time by means of incision size. In later days, invention of implantable, tolerable and technically feasible IOL was revolutionized in cataract surgery. In case of IOL material, Rigid or Polymethylmethacrylate (PMMA) was preferred intraocular lens material for a long time due to its lightness, clarity and stability, which were un-foldable lenses. Advancement in IOL material, PMMA are eventually replaced by silicone lens, hydrophilic and hydrophobic acrylic lenses. Moreover, continuous development in new intraocular lens (IOL) material and design has offered more options such as hydrogel, soft acrylic and silicone IOL. However, ease of use, availability, cost, and surgeon preference are also important factors, which influence IOL selection. Currently, key players in the intraocular lens market offers various types IOLs to improve the vision, which includes monofocal lens, multifocal lens, toric lens, accommodating lens, and trifocal lens.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/690

Increasing numbers of cataract surgeries, coupled with growing demand for multi-distance vision lens and significant increase in awareness programs for cataract patients by various government and private organizations are expected to augment growth of the intraocular lens market over the forecast period. Moreover, adoption of advanced technologies in cataract surgery and entry of various market players offering technologically advanced intraocular lens with affordable costs are further expected to drive growth of intraocular lens market.

The global intraocular lens market was valued at US$ 3.8 billion in 2017 and is expected to witness a CAGR of 7.5% over the forecast period (2017 – 2025).

Increasing number of Cataract Surgeries is expected to Drive Growth of the Intraocular Lens Market

Diabetes, prolonged exposure to sunlight, consumption of tobacco and alcohol are the major factors causing cataract and rising number of cataract patients increasing the demand for cataract surgeries. In addition to this, rising diabetes patients has led to increase in number of cataract surgery, as diabetes is a major cause of blindness. According to World Health Organization (WHO), around 422 million people were suffering from diabetes in 2014.

Increasing Governmental Initiatives and Awareness Programs for Cataract Patients is Driving Growth of the Intraocular Lens Market

Governmental and non-governmental organization are working together to spread awareness regarding cataract and associated conditions such as blindness. For instance, according to WHO in 2017, an estimated 253 million people had vision impairment worldwide, which creates the need for government to take initiatives and conduct awareness program for cataract patients. WHO and Task Force of International NGO have jointly prepared and launched a common agenda for global action called ‘The Vision 2020- the right to sight’ in 1999 with aim to eliminate blindness worldwide by 2020. This organization works jointly to mitigate implications of blindness in developmental, economic, social and quality of life terms, which is expected to augment the growth of intraocular lens market in near future.

Competitive Landscape

Major players operating in market include STAAR Surgical Company, HOYA Corporation, Lenstec, Inc., Ophtec BV, Johnson & Johnson, Alcon, Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Rayner Intraocular Lenses Limited, and HumanOptics AG.

Detailed Segmentation:

Global Intraocular Lens Market, By Flexibility:

Folded
Rigid

Global Intraocular Lens Market, By Product Type:

Premium Intraocular Lens
- Multifocal Intraocular lens
- Accommodating Intraocular lens
- Toric Intraocular lens
Monofocal Intraocular Lens
Preloaded Intraocular Lens
Others

For More Information, Browse Full Report Here: https://www.coherentmarketinsights.com/market-insight/intraocular-lens-market-690

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Cyber Knife Market Partake Significant Development During 2018 to 2026

Cyber knife is a non-invasive, painless robotic radiosurgery system used in the treatment of brain tumors such as malignant, and non-malignant tumors. It is also considered to be a radiosurgery device that do not require frame for targeting. It is also known as the synchrony system or synchrony method that uses a combination of surgical placed internal fiducials and light emitting optical fibers that is mounted on the patient body where the optical fibers are tracked by infrared tracking camera. Cyber knife radiosurgery benefit to patients who have previously received large doses of radiation therapy. The cyber knife radiosurgery treatment can be completed in 1 to 5 days treatment sessions with each treatment session lasts between 30 to 90 minutes. It can be used alone to treat the brain metastases.

Request For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/683

The cyber knife system comprises of diagnostic x-ray tube, 6 MV linear accelerator, secondary collimator, robot gantry, silicon X-ray detectors, and patient couch. Cyber knife systems has a Food and Drug Administration (FDA) clearance for the treatment of tumors such as head, neck cancers, spinal lesions, pancreas, and malignant tumors. Potential benefits of the cyber knife system includes no incision, no loss in blood, no pain, no overnight hospitalization, also it is faster and more accurate and patient can breathe normally during treatment. This treatment is based on the principle of destruction of cancerous cells by distracting their DNA by radiation, helps to slower the growth of cancerous cells.

Increase in incidences of cancer around the globe is expected to support the growth in cyber knife system market over the forecast period

Cyber knife is known for its radiology accuracy of 0.5 mm to 1.1 mm, which are used to treat cancerous cells or brain tumors. Geographically, North America and Europe regions are projected to lead the demand for cyber knife market due to the increase in geriatric population, prevalence of chronic diseases and growing demand for less time consuming treatments, increase in incidence of cancer and a shift towards painless and non-invasive surgeries. As owing to the large patient population pool in the countries such as China and India, cyber knife market is projected to grow in the forecast period.

In 2016, according to the American Cancer Society, it was estimated around 1,690,000 cases of cancer were diagnosed and around 596,000 cancer deaths occurred in the U.S. due to the increase in geriatric population, lack of physical exercise, over weight an and smoking accounts for high proportion of cancer worldwide, this is expected to led the demand for the cyber knife system in the near future.

The Major Key Players of Cyber Knife Market Includes:

Accuray Incorporated, BrainLab, Elekta AB, Nucletron B.V., GE Healthcare, Hitachi America, IBA Group, Mitsubishi Electric, Nordion, Philips Healthcare, RaySearch, Sumitomo Heavy Industries, Varian Medical Systems, Modus Medical Devices Inc., Varian Medical Systems International AG, GE Healthcare, Koninklijke Philips N.V., Toshiba Medical Systems Corporation, and Shenzhen GeneMDx Biotech. Co., Ltd.

Cyber Knife Market Taxonomy:

Cyber Knife Market by Application:

Tumor (lung, pancreatic, liver)
Cancer
Vascular malformation
Other

Cyber Knife Market End-User:

Hospitals
Ambulatory surgical centers
Clinics
Others

Browse Full Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/cyber-knife-market-683

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Tuesday, 14 May 2019

Medical Sensors Market Highly Favourable to the Growth Rate by 2018 to 2026

Medical sensors that measure the physical functions of the body and convert it into an electrical or optical signal. These devices play a major role in the monitoring of chronic diseases such as cancer, cardiovascular and respiratory diseases to measure the physical function and convert it into the electrical signal. The market is majorly directed by the increased demand for medical sensors in diagnostic and therapeutic segments. The medical sensor monitor adds value to the healthcare professional to alert critical deviations, which are recorded in vital signs. This ultimately improves the quality of care given to the patient by avoiding undesirable complications. Moreover, the demand for medical sensors is raised because of its wide range of applications such as monitoring of temperature, pressure, vibration, inclusive of various diagnostic parameters and analysis. As increase in chronic disorders and geriatric population globally has continuously raised the demand for these equipment. Furthermore, chronically ill patients and geriatric population are the target area for sensor-based devices, for instance as per National Institute of Aging, there are around 617 million people above the age of 65 years in 2016 and it will cross 1.6 billion by 2050.

Request For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/578

Improved Technology And Accuracy Fuels The Growth Of Medical Sensors Market

Medical sensors have become a universal segment of the technologically advanced and digital medical devices. There is a significant increase in the development of implantable and wearable medical devices, which facilitate the awareness about medical devices this leads to the increased use of sensors. It is expected that rise in geriatric population, increase in chronic diseases such as chronic obstructive pulmonary disease (COPD), cardiovascular disease, kidney disease and respiratory disease and rise in intensive care for critical patients are the responsible factors supports the growth of medical sensors market. As per Centers for Disease Control and Prevention, there are around 15.7 million people in the U.S. diagnosed with COPD in 2014. Furthermore, there is a wide range of benefits of the use of medical sensors in medical devices, which increased the accuracy in disease management through notifications alerts, and real time patient data communication. Which expected to support the growth of medical sensors market.

Developed Regions Are Major Growth Engines For Medical Sensors Market

Medical sensors market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America is the leading region due to the annual increase in minimally invasive surgeries performed and availability of healthcare reimbursement policy. However, market across Asia Pacific is expected to expand at a higher rate due to, increase in diabetic population, respiratory diseases cases, cardiovascular disease and raised investment in healthcare sector in emerging countries such as India and China expected to support the growth of medical sensors market.

Key Players of the Medical Sensors Market

There are various players present across the globe and running into the competition. The rise in awareness about devices and increase in per capita income of individuals expected to create more opportunities for industry players in global medical sensors market. Some key players are Analog Devices Inc., Broadcom Limited, Danaher, LORD Corporation, Honeywell International Inc., OmniVision Technologies Inc., and GE Measurement & Control.

Medical Sensors Market Taxonomy:

By Application -

Surgical
Diagnostic
Therapeutic
Monitoring

By Product Type -

Pressure
Temperature
Image
Accelerometers
Biosensors
Flow
Superconducting Quantum

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/medical-sensors-market-578

About Coherent Market Insights:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Parenteral Packaging Market In-deep Analysis and Experts Review Report 2017-2025

Parenteral packaging is the process of packaging drugs or other fluids to keep its potency and therapeutic effectiveness intact throughout the time till the drug is administered. Parental packaging is required to protect drugs from contamination and from the aseptic administration to the patient. On the basis of materials parenteral packaging market is segmented into plastic & polymer and glass segments. The plastic and polymer are more durably then glasses used for parenteral packaging. The pharmaceuticals sector has witnessed significant technological advancements in the recent past. As a result, recent advancement in routes of drug administration is shaping the market demand for parenteral packaging.

Request for Sample Copy of This Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/565

Continuous rise in chronic disease cases is expected to support the demand of parenteral drugs which in turn support the growth of parenteral packaging market in the near future. Asthma is one of the major chronic disease of air passages of the lungs. According to the World Health Organization (WHO) around 235 million people are suffering currently from asthma, it was estimated around 383,000 deaths occurred due to asthma in 2015 and the strong risk factor for asthma are inhaled substances and particles that causes allergic reaction which are exposed in environment. The fundamental causes of asthma can be tobacco smoke, chemical irritants at the workplace and air pollution.

The global parenteral packaging market was valued at US$ 7,845.7 million in 2016 and is expected to witness a robust CAGR of 11.1% during the forecast period (2017 – 2025)

Market Dynamics:

Increase in the prevalence of Alzheimer’s disease (AD) and aging population around the globe is expected to favor the growth in parenteral packaging market. According to the World Health Organization (WHO), the AD cases worldwide was estimated to be around 47 million and it will increase around 75 million by 2030 and the number of cases is expected to triple by 2050, due to the high prevalence rate and lack of healthcare services in rural areas. Also, increase in aging population and rise in demand for medication in the treatment of lifestyle diseases such as diabetes, are the other factors leading to the increase in use of parenteral drugs in developed and emerging economies. As per the SeniorCare the U.S. aging population was estimated to be around 50,683,620 in 2016 and is expected to be around 71,453,471 by the year 2030. And according to the National Institute on Aging (NIA) population worldwide is around 8.5% and it will rise around 17% by the year 2050.

Increase in incidence of cancer around the globe expected to support the growth of parenteral packaging market over the forecast period

North America holds the major market share, followed by Europe in the global parenteral packaging market. This is mainly due to rise in cancer case is projected to favor the growth of parenteral packaging market. According to the American Cancer Society (ACS) in the U.S. it was estimated that in 2016 around 1,685,210 cases of cancer was diagnosed and around 595,690 cancer deaths occurred this is due to the high risk factors such as smoking of cigarettes, consumption of alcohol and obesity rate this will led to the high proportion of chronic diseases in the U.S.

Market Top Key Players:

Key players in the parenteral packaging market include Gerresheimer AG, Schott AG, Becton, Unilife Corporation, Inc, Dickinson and Company, Ypsomed Holding AG, West Pharmaceutical Services, Inc., SiO2 Medical Products, Terumo Corporation, Ompi, Stevanato Group and Nipro Corporation, Berry Plastics Corporation, Becton Dickinson and Company, MeadWestvaco Corporation, Owens-Illinois, RPC Group, Schott Pharmaceuticals Services Inc., and Graphic Packaging Group.

Detailed Segmentation:

Parenteral Packaging Market, By Technique:

Bags and bottles
Ampoules
Vials
Prefilled syringes & cartridges
Ready-to-mix-systems

Parenteral Packaging Market, By Material:

Glass
Plastic and polymer
PVC
polyolefin

Browse Full Report Here: https://www.coherentmarketinsights.com/market-insight/parenteral-packaging-market-565

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Teleradiology Market Projected to Garner Significant Revenues by 2018 to 2026

Teleradiology is a method used to transmit medical radiological images such as x-rays, CTs, and MRIs, from one location to another location. The purpose of this transmission of medical images is to enable easy viewing and interpretation for diagnostic or consultation by a radiologist. The process of teleradiology involves an image sending station, a receiving image station, and a transmission network that has high quality screen, which has been cleared for clinical purposes. Teleradiology is a means for collaboration of medical professionals, despite their location. Increasing demand for second opinion for medical treatments is expected to boost growth of the market for teleradiology.

Teleradiology is widely used in application such as telediagnosis, telemonitoring, picture archiving and communication system (PACS), and teleconsultation. This increases the efficiency of the radiologist carrying out the surgery. Ultrasound is one of the most promising imaging technology in teleradiology, which is widely being used for diagnosing medical aliments in women. Ultrasound helps in tracking and visualization of the development stages of fetus during pregnancy. This in turn increases growth of the teleradiology market.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/549

Rising prevalence of chronic diseases to boost market growth

Rising prevalence of chronic disorders such as breast cancer, cellulitis, and osteomyelitis and the rising number of emergence cases in rural areas, which experiences the lack of skilled professional, are increasing demand for teleradiology services. Furthermore, rising expenditure on healthcare, improving healthcare infrastructure, and widening network of high-speed broadband services are expected to boost growth of the global market.

North America and Europe are expected to account for high market share, followed by Asia Pacific due to the rampant advancements in technology and high disposable income among the populace in the region. Increasing number of well-equipped healthcare centers and novel approaches to medicine are expected to fuel growth of the teleradiology market. Increasing incidence of chronic diseases such as cancer is creating a highly conducive environment for growth of the teleradiology market. For instance, according to the World Health Organization (WHO), in 2012, around 14 million cases of cancer were reported worldwide, leading to around 8.8 million deaths in 2015.

Key Players of Teleradiology Market:

Key players in the teleradiology market include Virtual Radiologic (vRAD), NightHawk Radiology, Inc., Sectra Imtec AB, StatRad, LLC, Agfa-Gevaert N.V., ONARD, Global Diagnostics, Everlight Radiology, 4ways Healthcare Limited, RamSoft, Inc., Sectra AB, Health Watch Tele Diagnostics Pvt. Ltd., Alta Vista Teleradiology, Argus Radiology, ONRAD, Inc., FujiFilm Medical Systems.

Teleradiology Market Taxonomy -

By Product:

Computed Tomography (CT)
X-ray
Ultrasound
Magnetic Resonance Imaging (MRI)
Nuclear Imaging

By Application:

Tele-diagnosis
Tele-consultation
Tele-monitoring
Picture Archiving and Communication System (PACS)
Radiology Information System (RIS)

Browse Complete Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/teleradiology-market-549

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Monday, 13 May 2019

Cosmetic Implants Market Developments in Infrastructure to Promote Growth 2026

Cosmetic Implants are substances placed under the skin or over the body to modify the beauty and physical appearance of an individual. Cosmetic implants are the specially designed medical devices which help individuals regain their appearance and aesthetically replace their damaged body parts after suffering from trauma or accidents. The implants can be placed subdermal or transdermal according to the type of surgical procedure. Cosmetic implants are prosthetics attempted to bring the desired portion of the body back to an acceptable aesthetic norm. Cosmetic implants have a wide applications in cosmetic industry providing higher psychological satisfaction to the people for decorative purposes. Tumor removal, laceration repair, maxillofacial surgery, scar revision and hand surgery are the common reconstruction procedures done by cosmetic implants. Breast augmentation continues to be the leading surgery technique while buttock augmentation, lower body lift and breast lift have shown rapid growth.

Request For Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/537

The exponential surge for cosmetic surgeries is expected to fuel growth of the global cosmetic implants market

According to the International Society of Plastic and Aesthetic Surgeons (ISAPS) 2013, around 23 million individuals underwent surgical and non-surgical cosmetic procedures globally. The key drivers are technological advancements such as injectable fillers and gummy bear breast implants, emerging minimally invasive reconstruction surgeries, rising number of tooth deformities, congenital face disorders and increasing awareness of aesthetic appearance. Biological cosmetic implant is a highly profitable segment owing to the health benefits of biological materials over synthetic materials. Also, the demand for polymer implant devices, demand for aesthetic procedures, emergence of innovative products like two form-stable silicone gel breast implants and hyaluronic acid facial filler are expected to boost the global cosmetic implants market in the forecast period. Rising awareness about safe inserts by empowering the female population to make wellness oriented decisions post breast cancer diagnosis will eventually impact the cosmetic implant market size.

Technological innovations like 3D printed facial implants is projected to have a positive impact on cosmetic implants market growth

The key players operating the global cosmetic implants market include Aesthetic and Reconstructive Technologies (AART) Inc., GC Aesthetics, Dentsply International Inc., Sientra Inc. The microchip implants, B lite implants are 30% lighter providing higher efficiency and reduced stress on the implanted organs. Other key vendors engage in continuous innovation with research and development for sustainable growth are Zimmer Holdings Inc., 3M Health Care, Implantech Associates Inc., Nobel Biocare Holding AG and Spectrum Designs Medical

Polymer based cosmetic implants is expected to contribute for a larger market share

The global cosmetic implants market is segmented on the basis of material, application, end user and geography.

On the basis of material, the global cosmetic implants market is segmented into:

Metals
Polymers
Ceramics
Biomaterials

On the basis of applications, the global cosmetic implants market is segmented into:

Dental Implants
- Root Form
- Plate Form
Breast Implants
- Saline-Filled
- Silicone Gel-Filled
Facial Implants
Others

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/cosmetic-implants-market-537

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Head and Neck Cancer Market Growth and Competitive Landscape to 2026

Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called tumor. This tumor can be cancerous or benign. Head and neck cancer is the terminology used to define a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and mouth. Furthermore, head and neck cancers initiate in squamous cells, cells that line moist surfaces such as those inside the head and neck (for example, the mouth, nose, and throat). Salivary glands have different types of cells that can turn cancerous. Chewing tobacco, excessive alcohol consumption, and infection with human papillomavirus (HPV) increases the risk of head and neck cancer. Other risk factors for head and neck cancers include excessive consumption of paan (betel quid), preserved or salted foods, oral health, occupational exposure, radiation exposure, Epstein barr virus infection, and due to hereditary causes.

Request For Sample Copy of This Research: https://www.coherentmarketinsights.com/insight/request-sample/530

Need for effective and targeted treatment is critical to increase the survival rates

Treatment of head and neck cancer is a major challenge for physicians, as the affectivity and choice of treatment varies from patient to patient and location of the tumor. Owing to complexity of facial structures and functions limits the surgical treatments for head and neck cancers, with surgery being the preferred mode of treatment. Post-surgery, functions such as chewing, talking, and swallowing may be adversely affected. Physicians opt for surgical therapy in combination with radiation therapy for treatment of the malady. Survival rate of head and neck cancer has reduced from 80% to 50% in last ten years, as currently available treatment options mainly treat the symptoms. Recent developments in the area of advanced chemotherapy and radiotherapy permit preserving some of the functions of the face. The introduction of targeted molecular therapy such as gene therapy, monoclonal antibodies, and antibody drug conjugates creates major growth avenues for the head and neck cancer market.

High incidence rate creates a potential growth opportunity for the market players

Growing occurrence of head and neck cancer and increasing research activities to develop cost-effective treatment options are the factors which are driving growth of the global head and neck cancer market. According to the World Health Organization, 3 - 5% of the population around the globe suffers from head and neck cancer. Moreover, worldwide approximately 550,000 new cases of head and neck cancer are diagnosed annually with almost 300,000 deaths annually. While the cancer can affect people across different age groups, it is especially prevalent among people over 50 years of age. Head and neck cancer is projected to result in 13,360 fatalities (3,420 women and 9,940 men) in 2017. These types of cancers are more than twice as common among men as women.

Global Top Players -

Key players operating in the head and neck cancer market are AB Science SA, Bayer AG, Bristol-Myers Squibb Company, Acceleron Pharma, Inc., Astellas Pharma Inc., Boston Biomedical, Inc., AbbVie Inc., and AstraZeneca Plc.

Head And Neck Cancer Market Taxonomy -

On the basis of disease indication, the global head and neck cancer market is classified into:

Laryngeal and Hypopharyngeal Cancer
Nasal Cavity and Paranasal Sinus Cancer
Nasopharyngeal Cancer
Oral and Oropharyngeal Cancer
Salivary Gland Cancer

On the basis of diagnostic methods, the global head and neck cancer market is classified into:

Diagnostic imaging equipment
Endoscopy screening equipment
Bioscopy screening tests
Blood tests
Dental diagnostic

Browse Full Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/head-and-neck-cancer-market-530

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Current Trends to 2026

Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that forms blood) in hematopoietic stem cell transplantation, in some cases cardiac cells are used productively to fix the damages due to heart attacks. Stem cell transplantation can be of two types - Autologous stem-cell transplantation and allogenic stem cell transplantation. In the later, the recipient and the donor of stem cells are dissimilar people. In a good number of allogeneic transplants, the stem cells are taken from a donor whose cell type matches closely with the patient’s cell type. The best donor in allogenic stem cell transplantation is an immediate family member, generally a brother or sister. If the patient does not have a match in his/her family, a donor may be found from the public. This is often called a MUD or matched unrelated donor transplant. This type of transplant (MUD) is generally riskier.

Request for Sample PDF Copy: https://www.coherentmarketinsights.com/insight/request-pdf/523

Increasing prevalence of cancer will drive the overall autologous stem cell and non-stem cell based therapies market

According to a report by National Cancer Institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S. alone. Moreover, it was also noted that around 595,690 people died from the disease in the same year. Autologous stem cell and non-stem cell based therapies is likely to become one of the preferred treatment for cancer. As the prevalence of cancer is rising at a considerable rate, the market is likely to grow during the forecast period.

North America, followed by Europe accounted for the major share of the autologous stem cell and non-stem cell based therapies market. This is due to minimization of risks related with the treatment. Moreover, the demand for these treatments is high due to their ability to cure a significant number of infectious diseases. Autologous stem cell and non-stem cell based therapies do not need an outside donor; therefore the treatment is less infectious and convenient. These factors are likely to boost the growth of the market in North America.

Global Top Players

Key players in the global autologous stem cell and non-stem cell based therapies market are investing heavily in their research and development activities so as to gain an upper hand in the market. Some of the major players operating in the market are NeoStem, Inc., Aastrom Biosciences, Fibrocell Science, Inc., Genzyme Corporation, BrainStorm Cell Therapeutics, Regeneus Ltd., and Dendreon Corporation.

Autologous stem cell and non-stem cell based therapies market Taxonomy

On the basis of application, the global autologous stem cell and non-stem cell based therapies market is classified into:

- Neurodegenerative diseases

- Cardiovascular diseases

- Cancer and autoimmune diseases

- Skin transplantation

- Infectious disease

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/autologous-stem-cell-and-non-stem-cell-based-therapies-market-523

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Saturday, 4 May 2019

Extracorporeal Shock Wave Lithotripsy Market To See Incredible Growth By 2026

Extracorporeal shock wave lithotripsy is a non-invasive treatment for kidney stone and biliary calculi, using an acoustic pulse and are also used for salivary stones and pancreatic stones. The lithotripter supplies a high intensity acoustic pulse to crush the stone causing minimal collateral damage to the normal tissue and the shock waves break the stones into smaller portion. Extracorporeal shock wave lithotripsy are widely used by the physician globally due to its important characteristic such as non-invasiveness, recovery time, reduced pain and reduced hospital stay. Extracorporeal shock wave lithotripsy success rate is high for patients with smaller stones such as less than 1 centimeter. Also, rise in prevalence of obesity and increasing diabetic patient population also favors growth of the extracorporeal shock wave lithotripsy market.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/513

Extracorporeal shock wave lithotripsy market is being fuelled by rise in incidence of kidney stones

Extracorporeal shock wave lithotripsy is a valuable tool for eradication of stones from kidney, ureter, gallbladder, salivary gland, or salivary duct. Extracorporeal shock wave lithotripsy is used to find the stone and break it down into smaller fragments. Extracorporeal shock wave lithotripsy generates shockwaves, which are then focused onto the stone present in body with negligible diversion of energy that favors minimal damage to tissue. Extracorporeal shock wave lithotripsy is also most effective in treatment of non-obstructing renal calculi. Whereas the composition and density of stone decides the rate of shockwaves to be generated. According to Centers for Disease Control and Prevention, number of adults diagnosed by kidney disease are 4.9 million in the U.S. in 2015.

Growth engines for extracorporeal shock wave lithotripsy market

Most populated and urbanized regions such as North America, Asia-pacific and European region in the world that uses the advanced devices for treatment purpose shows the largest extracorporeal shock wave lithotripsy market. Europe also favors the growth of market due to increased government investment. The high growth in India and China can be attributed to government and venture capital investments in the field of extracorporeal shock wave lithotripsy to develop the market. Increase in incidence of kidney stone disease in the U.S. also favors the market of extracorporeal shock wave lithotripsy.

The key players dominating the global extracorporeal shock wave lithotripsy market

Investment in medical device technology and R&D have increased the competition among the manufacturers. Whereas manufacturers are focusing on offering advanced features to extracorporeal shock wave lithotripsy at affordable prices to gain a competitive edge in the market. The key players operating in the market are Boston Scientific Corporation, C.R. Bard Inc., Lumenis LTD, GE Healthcare and Siemens AG.

Extracorporeal Shock Wave Lithotripsy Market Taxonomy -

By Technology:

Electrohydraulic Technique
Electromagnetic Technique
Piezoelectric Technique

By Application:

Kidney Stones
Uretic Stones
Pancreatic Stones
Salivary Stones

Browse Full Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/extracorporeal-shock-wave-lithotripsy-market-513

About Coherent Market Insights:

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com